Outstanding Reviewers for RSC Pharmaceutics in 2024

---

Abstract

We would like to take this opportunity to thank all of RSC Pharmaceutics’ reviewers for helping to preserve quality and integrity in pharmaceutics literature. We would also like to highlight the Outstanding Reviewers for RSC Pharmaceutics in 2024.

---

Each one of our outstanding peer reviewers has been carefully selected by our editorial team, and the list includes active researchers who have made significant contributions to peer review and have gone above and beyond in their actions. In recognition of the varied contributions of our reviewer community, our Outstanding Reviewers from 2024 have been chosen based on several different measures, including the number, timeliness, and quality of the reports completed during 2024. We also highlight reviewers who have provided exceptionally thorough and detailed reports, as well as reviewers who have made additional efforts to aid authors in improving their manuscripts.

RSC Pharmaceutics strives to represent the diversity of the pharmaceutics community, and we would like our reviewer community to reflect that. We are always looking to improve the diversity of our reviewer community in all its forms, and welcome applications for new reviewers through the RSC's Become a Reviewer page.

“Our reviewers are the foundation of RSC Pharmaceutics. Their expertise, time, and thoughtful evaluations are essential in upholding the scientific quality and integrity of the journal. We are deeply grateful for their vital contribution to advancing pharmaceutical science through rigorous and fair peer review” – Yvonne Perrie, Editor-in-Chief.

 

Dr Basanth Babu Eedara

Transpire Bio Inc

ORCID: https://orcid.org/0000-0002-8462-4181

 

Dr David Encinas-Basurto

University of Sonora

ORCID: https://orcid.org/0000-0002-4988-9192

 

Dr Naved Anjum Malek

Sardar Vallabhbhai National Institute of Technology

ORCID: https://orcid.org/0000-0002-2164-5268

 

Dr Alejandro Paredes

Queen's University Belfast

ORCID: https://orcid.org/0000-0002-0414-8972

 

Professor Tze Ning Hiew

The University of Iowa

ORCID: https://orcid.org/0000-0002-2313-7806

Professor Shu-Qin Yu

Nanjing Normal University

ORCID: https://orcid.org/0000-0002-2824-4651

 

Dr Zvi Yaari

The Hebrew University of Jerusalem

ORCID: https://orcid.org/0000-0002-1889-1994

 

Dr Mohd Kalam

King Saud University

ORCID: https://orcid.org/0000-0002-5713-8858

 

Professor Yun-Long Wu

Xiamen University

ORCID: https://orcid.org/0000-0001-6426-6340

 

We would also like to thank the RSC Pharmaceutics Editorial Board and Advisory Board and the pharmaceutics community for their continued support of the journal, as authors, reviewers and readers.

We continue to work on improving the diversity of our reviewer pool to reflect the diversity of the communities that we serve.

 

Laura Fisher, Executive Editor

Yvonne Perrie, Editor-in-Chief

---